CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (14,311)	$ (13,656)
Adjustments required to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	146	85
Change in liability for employees right upon retirement	141	35
Financial expenses	2,707	246
Royalties buyout expenses	918
Share-based compensation expenses	2,730	9,799
Loss (gains) on amounts funded in respect of employee rights upon retirement, net	(3)	5
Changes in operating asset and liability items:
Decrease (increase) in prepaid expenses	2	(18)
Increase in trade receivables	(322)	(1,428)
Increase in other receivables	(14)	(33)
Decrease in inventory on consignment	63	23
Increase in inventory on hand	(238)	(546)
Decrease in trade payables	(65)	(512)
Increase in deferred revenues		25
Increase (decrease) in other payables and advance payment from customers	(370)	179
Net cash used in operating activities	(8,616)	(5,796)
CASH FLOWS FROM INVESTING ACTIVITIES:
Decrease (increase) in restricted cash	(54)	304
Purchase of property, plant and equipment	(118)	(176)
Proceeds from sale of property, plant and equipment		12
Amounts funded in respect of employee rights upon retirement	(95)	(31)
Net cash provided by (used in) investing activities	(267)	109
CASH FLOWS FROM FINANCING ACTIVITIES:
Exercise of options and warrants	1,049	1,500
Shares of common stock used to satisfy tax withholding obligations	(20)
Repayment of long-term loan		(281)
Net cash provided by financing activities	1,029	1,219
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	84	(251)
DECREASE IN CASH AND CASH EQUIVALENTS	(7,770)	(4,719)
BALANCE OF CASH AND CASH EQUIVALENTS AT BEGINNING OF THE PERIOD	10,284	8,070
BALANCE OF CASH AND CASH EQUIVALENTS AT END OF THE PERIOD	2,514	3,351
Purchasing of property, plant and equipment on credit and in consideration of share-based payment		62
Royalties buyout in consideration of shares and waiver	930
Deferred issuance costs included in trade and other payables	$ 287